Rapid growing mycobacteria and TNF-α blockers: Case report of a fatal lung infection with Mycobacterium abscessus in a patient treated with infliximab, and literature review

Clinical and Experimental Rheumatology

Volumn 29, Issue 4, 2011, Pages 705-707

  Besada, Emilio ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Infliximab; Mycobacteria; Mycobacterium abscessus; Non tuberculous; Rapid growing mycobacteria; TNF blocker

Indexed keywords

AMIKACIN; CLARITHROMYCIN; INFLIXIMAB; LINEZOLID; ANTIINFECTIVE AGENT; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BRONCHOSCOPY; CASE REPORT; CROHN DISEASE; HUMAN; HUMAN TISSUE; LATENT TUBERCULOSIS; LOBECTOMY; LUNG BIOPSY; LUNG INFECTION; LUNG LAVAGE; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY FAILURE; WEIGHT REDUCTION; AGED; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; COMPUTER ASSISTED TOMOGRAPHY; FATALITY; FEMALE; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; LUNG RESECTION; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM; RESPIRATORY TRACT INFECTION; REVIEW; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; BRONCHOALVEOLAR LAVAGE FLUID; CROHN DISEASE; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; PNEUMONECTOMY; RESPIRATORY TRACT INFECTIONS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 80055088666     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Arend SM, Van Soolingen D, Ottenhoff THM: Diagnosis and treatment of lung infection with nontuberculous mycobacteria. Curr Opin Pulm Med 2009; 15: 201-208.
2. Thomas JE, Taoka CR, Gibbs BT, Fraser SL: Fatal pulmonary Mycobacterium abscesus infection in a patient using Etanercept. Hawaii Med J 2006; 65: 12-15.
3. Mufti AH, Toye BW, Mckendry RR, Angel JB: Mycobacterium abscessus infection after use of tumor necrosis factor a inhibitor therapy: case report and review of infectious complications associated with tumour necrosis factor a inhibitor use. Diagn Microbiol Infect Dis 2005; 53: 233-238.
4. Boulman N, Rozenbaum M, Slobodin G, Rosner I: Mycobacterium fortuitum infection complicating infliximab therapy in rheumatoid arthritis. Clin Exp Rheumatol 2006; 24: 723.
5. Adenis-Lamarre E, Kostrzewa E, Texier-Maugein J, Doutre MS: Infection cutanee à Mycobacterium chelonae au cours d'un traitement par anti-TNF. Ann Dermatol Venereol 2009; 136: 811-814.
6. Sicot N, Gaultier JB, Parize P, Puget M, Rousset H: Infection cutanee disseminee à Mycobacterium chelonae mimant une poussee de vascularite. Revue Med Interne 2006; 27: S387-S388.
7. Diaz F, Urkijo JC, Mendoza F et al.: Mycobacterium chelonae infection associated with adalimumab therapy. Scand J Rheumatol 2008; 37: 159-160.
8. Kluger N, Cohen P, Fallet-Bianco C, Guillevin L: Mycobacterium chelonae infection under adalimumab therapy for spondyloarthritis. Clin Exp Rheumatol 2010; 28:101-102.
9. Stewart MW, Alvarez S, Ginsburg WW, Shetty R, Mclain WC, Sleater JP: Visual recovery following Mycobacterium chelonae endophtalmitis. Ocul Immunol Inflamm 2006; 14: 181-183.
10. Winthrop KL, Chang E, Yamashita S, Iademarco MF, Lobue PA: Nontuberculous mycobacteria infections and anti-Tumor Necrosis Factor-a therapy. Emerg Infect Dis 2009; 15: 1556-1561.
11. Griffith DE: Nontuberculous mycobacterial lung disease. Curr Opin Infect Dis 2010; 23: 185-190.
12. Piersimoni C, Scarparo C: Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients. Lancet Infect Dis 2008; 8: 323-334.
13. Jeon K, Kwon OJ, Lee NY et al.: Antibiotic treatment of Mycobacterium abscessus lung disease. A retrospective analysis of 65 patients. Am J Respir Crit Care Med 2009; 180:896-902.
14. Mitchell JD, Bishop A, Cafaro A, Weyant MJ, Pomerantz M: Anatomic lung resection for nontuberculous mycobacterial disease. Ann Thorac Surg 2008; 85:1887-1893.
15. Cassidy PM, Hedberg K, Saulson A, Mcnelly E, Winthrop KL: Nontuberculous mycobacterial disease prevalence and risks factors: a changing epidemiology. Clin Infect Dis 2009; 49: e124-e129.